miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells

By Guo Haizhou   Li Qianping   Li Weihao   Zheng Tianliang   Zhao Song   Liu Zhangsuo  

Molecular and Cellular Biochemistry, Vol. 390, Iss. 1-2, 2014-05 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

miR‐134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non‐small cell lung cancer cells

By  

FEBS Open Bio, Vol. 586, Iss. 20, 2012-10 ,pp. : 3761-3765

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored in silico using RNA‐sequencing and microarray data

By  

FEBS Open Bio, Vol. 8, Iss. 1, 2018-01 ,pp. : 94-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma

By Wu Chaohui   Li Minjie   Hu Chao   Duan Hongbing  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1257-1266

Springer Publishing Company

Access to resources Recommend Favorite

Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer

By Chen Chi-qi   Chen Cheng-shui   Chen Jun-jie   Zhou Lian-ping   Xu Hong-lei   Jin Wei-wei   Wu Jian-bo   Gao Shen-meng  

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 137-148

Springer Publishing Company

Access to resources Recommend Favorite